Precious studies demonstrated that SSTR2 might serve as a molecular target in the diagnosis and treatment of thyroid cancer (Thakur et al., 2021), small intestinal neuroendocrine tumor (Elf et al., 2021), and neuroendocrine tumors (Si et al., 2021). This evidence concerns the gene SSTR2 and thyroid cancer.